Contribution of APOA5-1131C allele to the increased susceptibility of diabetes mellitus in association with higher triglyceride in Korean women

Metabolism: Clinical and Experimental

Volumn 59, Issue 11, 2010, Pages 1583-1590

  Lee, Ki Ho ^a,b   Kim, Oh Yoen ^a   Lim, Hyo Hee ^a   Lee, Young Jin ^b   Jang, Yangsoo ^a,c   Lee, Jong Ho ^a  

^a Yonsei University   (South Korea)

^b Department of Obstetrics and Gynecology   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A5; APOLIPOPROTEIN B; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; ALLELE; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; DIABETIC PATIENT; DIET RESTRICTION; DISEASE ASSOCIATION; DRINKING; FEMALE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GLUCOSE BLOOD LEVEL; HETEROZYGOTE; HIGH RISK PATIENT; HOMOZYGOTE; HUMAN; HYPERGLYCEMIA; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MENOPAUSE; PRIORITY JOURNAL; SCREENING TEST; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL;

ALLELES; APOLIPOPROTEINS A; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; DIABETES MELLITUS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; KOREA; ODDS RATIO; TRIGLYCERIDES;

EID: 78049261051     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2010.02.008     Document Type: Article

References (48)

1. Pennacchio L.A., Olivier M., Hubacek J.A., Cohen J.C., Cox D.R., and Fruchart J.C. An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing Science 294 2001 169 173
2. Jang Y., Kim J.Y., Kim O.Y., Lee J.E., Cho H., and Ordovas J.M. The -1131T>C polymorphism in the apolipoprotein A5 gene is associated with postprandial hypertriacylglycerolemia; elevated small, dense LDL concentrations; and oxidative stress in nonobese Korean men Am J Clin Nutr 80 2004 832 840
3. Kim J.Y., Kim O.Y., Koh S.J., Jang Y., Yun S.S., and Ordovas J.M. Comparison of low-fat meal and high-fat meal on postprandial lipemic response in non-obese men according to the -1131T>C polymorphism of the apolipoprotein A5 (APOA5) gene (randomized cross-over design) J Am Coll Nutr 25 2006 340 347
4. Bi N., Yan S.K., Li G.P., Yin Z.N., and Chen B.S. A single nucleotide polymorphism -1131T>C in the apolipoprotein A5 gene is associated with an increased risk of coronary artery disease and alters triglyceride metabolism in Chinese Mol Genet Metab 83 2004 280 286
5. Nabika T., Nasreen S., Kobayashi S., and Masuda J. The genetic effect of the apoprotein AV gene on the serum triglyceride level in Japanese Atherosclerosis 165 2002 201 204
6. Endo K., Yanagi H., Araki J., Hirano C., Yamakawa-Kobayashi K., and Tomura S. Association found between the promoter region polymorphism in the apolipoprotein A-V gene and the serum triglyceride level in Japanese schoolchildren Hum Genet 111 2002 570 572
7. Pennacchio L.A., Olivier M., Hubacek J.A., Krauss R.M., Rubin E.M., and Cohen J.C. Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels Hum Mol Genet 11 2002 3031 3038
8. Evans D., Buchwald A., and Beil F.U. The single nucleotide polymorphism -1131T>C in the apolipoprotein A5 (APOA5) gene is associated with elevated triglycerides in patients with hyperlipidemia J Mol Med 81 2003 645 654
9. Ribalta J., Figuera L., Fernandez-Ballart J., Vilella E., Castro Cabezas M., and Masana L. Newly identified apolipoprotein AV gene predisposes to high plasma triglycerides in familial combined hyperlipidemia Clin Chem 48 2002 1597 1600
10. Hubacek J.A. Apolipoprotein A5 and triglyceridemia. Focus on the effects of the common variants Clin Chem Lab Med 43 2005 897 902
11. Chandak G.R., Ward K.J., Yajnik C.S., Pandit A.N., Bavdekar A., and Joglekar C.V. Triglyceride associated polymorphisms of the APOA5 gene have very different allele frequencies in Pune, India, compared to Europeans BMC Med Genet 7 2006 76
12. Lai C.Q., Parnell L.D., and Ordovas J.M. The APOA1/C3/A4/A5 gene cluster, lipid metabolism and cardiovascular disease risk Curr Opin Lipidol 16 2005 153 166
13. Dallongeville J., Cottel D., Wagner A., Ducimetière P., Ruidavets G.B., and Arveiler D. The APOA5 Trp19 allele is associated with metabolic syndrome via its association with plasma triglycerides BMC Medical Genetics 9:84 2008 1 9
14. Lai C.Q., Tai E.S., Tan C.E., Cutter J., Chew S.K., and Zhu Y.P. The APOA5 locus is a strong determinant of plasma triglyceride concentrations across ethnic groups in Singapore J Lipid Res 44 2003 2365 2373
15. Talmud P.J., Hawe E., Martin S., Olivier M., Miller G.J., and Rubin E.M. Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides. Hum Mol Genet 11 2002 3039 3046
16. Hubacek J.A., Škodova' Z., Ada'mkova' V., La'nska' V., and Poledne R. The influence of APOAV polymorphisms (T-1131>C and S19>W) on plasma triglyceride levels and risk of myocardial infarction Clin Genet 65 2004 126 130
17. Szalai C., Keszei M., and Duba J. Polymorphism in the promoter region of the apolipoprotein A5 gene is associated with an increased susceptibility for coronary artery disease Atherosclerosis 173 2004 109 114
18. Jang Y., Paik J.K., Hyun Y.J., Chae J.S., Kim J.Y., and Choi J.R. The apolipoprotein A5 -1131T>C promoter polymorphism in Koreans: association with plasma APOA5 and serum triglyceride concentrations, LDL particle size and coronary artery disease Clin Chim Acta 402 2009 83 87
19. Hubacek J.A., Kovář J., Škodová Z., Pit'haa J., La'nská V., and Poledne R. Genetic analysis of APOAV polymorphisms (T-1131/C, Ser19/Trp and Val153/Met): no effect on plasma remnant particles concentrations Clin Chim Acta 348 2004 171 175
20. Lai C.Q., Demissie S., and Cupples L.A. Influence of the APOA5 locus on plasma triglyceride, lipoprotein subclasses, and CVD risk in the Framingham Heart Study J Lipid Res 45 2004 2096 2105
21. Hsu L.A., Ko Y.L., and Chang C.J. Genetic variations of apolipoprotein A5 gene is associated with the risk of coronary artery disease among Chinese in Taiwan Atherosclerosis 185 2006 143 149
22. Lee K.W.J., Ayyobi A.F., Frohlich J.J., and Hil J.S. APOA5 gene polymorphism modulates levels of triglyceride, HDL cholesterol and FERHDL but is not a risk factor for coronary artery disease Atherosclerosis 176 2004 165 172
23. Mar R., Pajukanta P., Allayee H., Groenendijk M., Dallinga-Thie G., and Krauss R.M. Association of the apolipoprotein A1/C3/A4/A5 gene cluster with triglyceride levels and LDL particle size in familial combined hyperlipidemia Circ Res 94 2004 993 999
24. Lehto S., Ronnemaa T., Haffner S.M., Pyorala K., Kallio V., and Laakso M. Dyslipidemia and hyperglycemia predict coronary heart disease events in middle-aged patients with type 2 diabetes Diabetes 48 1997 1354 1359
25. Teno S., Uto Y., Nagashima H., Endoh Y., Iwamoto Y., and Omori Y. Association of postprandial hypertriglyceridemia and carotid intima-media thickness in patients with type 2 diabetes Diabetes Care 23 2000 1401 1406
26. Qi L., Liu S., Rifai N., Hunter D., and Hu F.B. Associations of the apolipoprotein A1/C3/A4/A5 gene cluster with triglyceride and HDL cholesterol levels in women with type 2 diabetes Atherosclerosis 92 2007 204 210
27. Dorfmeister B., Cooper J.A., Stephens J.W., Ireland H., Hurel S.J., and Humphries S.E. The effect of APOA5 and APOC3 variants on lipid parameters in European whites, Indian Asians and Afro-Caribbeans with type 2 diabetes Biochim et Biophys Acta 1772 2007 355 363
28. Zhai G.H., Wen P., Guo L.F., and Chen L. Association of apolipoprotein A5 gene -1131T/C polymorphism with lipid metabolism and insulin resistance in patients with type II diabetes mellitus Yi Chuan 29 2007 541 546
29. Yan S.K., Cheng X.Q., Song Y.H., Xiao X.H., Bi N., and Chen B.S. Apolipoprotein A5 gene polymorphism -1131T>C: association with plasma lipids and type 2 diabetes mellitus with coronary heart disease in Chinese Clin Chem Lab Med 43 2005 607 612
30. Talmud P.J., Cooper J.A., Hattori H., Miller I.P., Miller G.J., and Humphries S.E. The apolipoprotein A-V genotype and plasma apolipoprotein A-V and triglyceride levels: prospective risk of type 2 diabetes. Results from the Northwick Park Heart Study II Diabetologia 49 2006 2337 2340
31. Cardona F., Guardiola M., Queipo-Ortuño M.I., Murri M., Ribalta J., and Tinahones F.J. The -1131T>C SNP of the APOA5 gene modulates response to fenofibrate treatment in patients with the metabolic syndrome: a postprandial study Atherosclerosis 206 2009 148 152
32. Merkel M., Loeffler B., Kluger M., Fabig N., Geppert G., and Pennacchio L.A. Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan-bound lipoprotein lipase J Biol Chem 280 2005 21553 21560
33. Schaap F.G., Rensen P.C., Voshol P.J., Vrins C., van der Vliet H.N., and Chamuleau R.A. ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis J Biol Chem 279 2004 27941 27947
34. Rensen P.C.N., Frants R.R., van Tol A., Hattori H., Smelt A.H.M., and van Dijk K.W. Plasma apoA-V levels are markedly elevated in severe hypertriglyceridemia and positively correlated with the apoA5S19W polymorphism Atherosclerosis 193 2007 129 134
35. Schaap F.G., Nierman M.C., Berbe'e J.F.P., Hattori H., Talmud P.J., and Vaessen S.F.C. Evidence for a complex relationship between apoA-V and apoC-III in patients with severe hypertriglyceridemia J Lipid Res 7 2006 2333 2339
36. Hirano T., Hayashi T., Adachi M., Taira T., and Hattori H. Marked decrease of apolipoprotein AV in both diabetic and nondiabetic patients with end-stage renal disease Metabolism 56 2007 462 463
37. Pruneta-Deloche V., Ponsin G., Groisne L., Fruchart-Najib J., Lagarde M., and Moulin P. Postprandial increase of plasma apoAV concentrations in type 2 diabetic patients Atherosclerosis 181 2005 403 405
38. Hyun Y.J., Jang Y., Chae J.S., Kim J.Y., Paik J.K., and Kim S.Y. Association of apolipoprotein A5 concentration with serum insulin and triglyceride levels and coronary artery disease in Korean men Atherosclerosis 205 2009 568 573
39. Nowak M., Helleboid-Chapman A., Jakel H., Martin G., Duran-Sandoval D., and Staels B. Insulin-mediated downregulation of apolipoprotein A5 gene expression through the phosphatidylinositol 3-kinase pathway: role of upstream stimulatory factor Mol Cell Biol 25 2005 1537 1548
40. G.M. Dallinga-Thie, van Tol A., Hattori H., van Vark-vander Zee L.C., Jansen H., and Sijbrands H.E.J.G. Plasma apolipoprotein A5 and triglycerides in type 2 diabetes Diabetologia 49 2006 1505 1511
41. Kahri J., Matikainen N., Vakkilaine J., Fruchart-Najib J., Fruchart J.C., and Taskinen M.R. The Increase of apolipoprotein A-V during postprandial lipemia parallels the response of triglyceride-rich lipoproteins in type 2 diabetes Diabetes Care 30 2007 2083 2085
42. Alborn W.E., Prince M.J., and Konrad R.J. Relationship of apolipoprotein A5 and apolipoprotein C3 levels to serum triglycerides in patients with type 2 diabetes Clin Chim Acta 378 2007 154 158
43. Prieur X., Lesnik P., Moreau M., Rodríguez J.C., Doucet C., and Chapman M.J. Differential regulation of the human versus the mouse apolipoprotein AV gene by PPARalpha Implications for the study of pharmaceutical modifiers of hypertriglyceridemia in mice Biochim Biophys Acta 1791 2009 764 771
44. Talmud P.J., Palmen J., Putt W., Lins L., and Humphries S.E. Determination of the functionality of common APOA5 polymorphisms J Biol Chem 280 2005 28215 28220
45. Li W.W., Dammerman M.M., Smith J.D., Metzger S., Breslow J.L., and Leff T. Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia. J Clin Invest 96 1995 2601 2605
46. Waterworth D.M., Talmud P.J., Luan J., Flavell D.M., Byrne C.D., and Humphries S.E. Variants in the APOC3 promoter insulin responsive element modulate insulin secretion and lipids in middle-aged men. Biochim Biophys Acta 2003 1637 200 206
47. Nowak M., Helleboid-Chapman A., Jakel H., Moitrot1 E., Rommens C., and Pennacchio L.A. Glucose regulates the expression of the apolipoprotein A5 gene J Mol Biol 380 2008 789 798
48. Chiu K.C., Chiu Y.F., Boyadjian A.A., Fernando S., Kwan C., and Chuang L.M. Impact of apolipoprotein A5 polymorphisms on insulin sensitivity and beta-cell function Pancreas 30 2005 328 332